Prevention of toxoplasmosis during pregnancy - An epidemiologic survey over 22 consecutive years

Journal of Perinatal Medicine

Volumn 32, Issue 3, 2004, Pages 211-214

  Breugelmans, Maria ^a,b   Naessens, Anne ^a   Foulon, Walter ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Congenital toxoplasmosis; Health promotion; Prevention

Indexed keywords

ARTICLE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; GESTATIONAL AGE; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PATIENT EDUCATION; PRENATAL CARE; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PRIORITY JOURNAL; SEROCONVERSION; SERODIAGNOSIS; TOXOPLASMOSIS; TREATMENT PLANNING; UMBILICAL CORD BLOOD;

BELGIUM; FEMALE; HEALTH PROMOTION; HUMANS; INCIDENCE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL CARE; TOXOPLASMOSIS, CONGENITAL;

EID: 2942563894     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPM.2004.039     Document Type: Article

References (14)

1. Aspöck H, A Pollak: Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl 84 (1992) 32
2. Aspöck H: Prevention of congenital toxoplasmosis in Austria: experience of 25 years. In: Ambroise-Thomas P, E Petersen (eds): Congenital toxoplasmosis. Springer-Verlag, Paris 2000
3. Brezin AP, P Thulliez, J Couvreur, R Nobre, R Mcleod, MB Mets: Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol 135 (2003) 779
4. Carter AO, SB Gelmon, GA Wells, AP Toepell: The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis. Epidemiol Infect 103 (1989) 539
5. Foulon W, A Naessens, D Ho-Yen: Prevention of congenital toxoplasmosis. J Perinat Med 28 (2000) 337
6. Foulon W, A Naessens, MP Derde: Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol 11 (1994) 57
7. Foulon W, A Naessens, M Volckaert, S Lauwers, JJ Amy: Congenital toxoplasmosis: a prospective survey in Brussels. Br J Obstet Gynaecol 91 (1984) 419
8. Foulon W, I Villena, B Stray-Pedersen, A Decoster, M Lappalainen, JM Pinon, PA Jenum, K Hedman, A Naessens: Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 180 (1999) 410.
9. th ed., WB Saunders, Philadelphia 1995
10. Stray-Pedersen B: Prevention of congenital toxoplasmosis in Norway. Arch Pediatr 10 (2003) 23.
11. Villena I, D Aubert, B Leroux, D Dupouy, M Talmud, C Chemla, T Trenque, G Schmit, C Quereux, M Guenounou, M Pluot, A Bonhomme, JM Pinon: Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis 30 (1998) 295
12. Villena I, C Quereux, JM Pinon: Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination. Prenat Diagn 18 (1998) 754
13. Wallon M, MR Mallaret, M Mojon, F Peyron: Congenital toxoplasmosis, evaluation of the prevention policy. Presse Med 23 (1994) 1467
14. Wilson CB, JS Remington: What can be done to prevent congenital toxoplasmosis? Am J Obstet Gynecol 15 (1980) 357